APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Preventive Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Preventive Vaccines Market Analysis and Forecast 2026-2032

Report ID 174028430222 December 2025190 pages

Choose your research edition.

Industry ResearchPreventive Vaccines Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Preventive Vaccines Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Preventive Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Preventive Vaccines Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Preventive Vaccines Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Preventive Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Preventive Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Preventive Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Preventive Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Preventive Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Preventive Vaccines include Abbott, Sanofi, GlaxoSmithKline, AstraZeneca, Serum Institute of India and CSL Ltd, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Preventive Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Preventive Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Preventive Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Preventive Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Preventive Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Preventive Vaccines sales, projected growth trends, production technology, application and end-user industry.

Preventive Vaccines Segment by Company

Abbott

Sanofi

GlaxoSmithKline

AstraZeneca

Serum Institute of India

CSL Ltd

Preventive Vaccines Segment by Type

Intradermal Shot

Intramuscular Injection

Nasal Spray

Preventive Vaccines Segment by Application

Hospital

Clinic

Other

Preventive Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Preventive Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Preventive Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Preventive Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Preventive Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Preventive Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Preventive Vaccines sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Preventive Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Intradermal Shot Major Manufacturers Table 3. Intramuscular Injection Major Manufacturers Table 4. Nasal Spray Major Manufacturers Table 5. Global Preventive Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Major Manufacturers Table 7. Clinic Major Manufacturers Table 8. Other Major Manufacturers Table 9. Preventive Vaccines Industry Trends Table 10. Preventive Vaccines Industry Drivers Table 11. Preventive Vaccines Industry Opportunities and Challenges Table 12. Preventive Vaccines Industry Restraints Table 13. Global Preventive Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Preventive Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Preventive Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Preventive Vaccines Revenue Market Share by Region (2021-2026) Table 17. Global Preventive Vaccines Revenue Market Share by Region (2027-2032) Table 18. Global Preventive Vaccines Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (doses) Table 19. Global Preventive Vaccines Sales by Region (2021-2026) & (doses) Table 20. Global Preventive Vaccines Sales by Region (2027-2032) & (doses) Table 21. Global Preventive Vaccines Sales Market Share by Region (2021-2026) Table 22. Global Preventive Vaccines Sales Market Share by Region (2027-2032) Table 23. Global Preventive Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Preventive Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Preventive Vaccines Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Preventive Vaccines Sales Market Share by Manufacturers (2021-2026) Table 27. Global Preventive Vaccines Sales Price (US$/dose) of Manufacturers (2021-2026) Table 28. Global Preventive Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Preventive Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Preventive Vaccines Manufacturers, Product Type & Application Table 31. Global Preventive Vaccines Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Preventive Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Preventive Vaccines Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Preventive Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Preventive Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Preventive Vaccines Revenue Market Share by Type (2021-2026) Table 38. Global Preventive Vaccines Revenue Market Share by Type (2027-2032) Table 39. Global Preventive Vaccines Sales by Type 2021 VS 2025 VS 2032 (doses) Table 40. Global Preventive Vaccines Sales by Type (2021-2026) & (doses) Table 41. Global Preventive Vaccines Sales by Type (2027-2032) & (doses) Table 42. Global Preventive Vaccines Sales Market Share by Type (2021-2026) Table 43. Global Preventive Vaccines Sales Market Share by Type (2027-2032) Table 44. Global Preventive Vaccines Price by Type (2021-2026) & (US$/dose) Table 45. Global Preventive Vaccines Price by Type (2027-2032) & (US$/dose) Table 46. Global Preventive Vaccines Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Preventive Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Preventive Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Preventive Vaccines Revenue Market Share by Application (2021-2026) Table 50. Global Preventive Vaccines Revenue Market Share by Application (2027-2032) Table 51. Global Preventive Vaccines Sales by Application 2021 VS 2025 VS 2032 (doses) Table 52. Global Preventive Vaccines Sales by Application (2021-2026) & (doses) Table 53. Global Preventive Vaccines Sales by Application (2027-2032) & (doses) Table 54. Global Preventive Vaccines Sales Market Share by Application (2021-2026) Table 55. Global Preventive Vaccines Sales Market Share by Application (2027-2032) Table 56. Global Preventive Vaccines Price by Application (2021-2026) & (US$/dose) Table 57. Global Preventive Vaccines Price by Application (2027-2032) & (US$/dose) Table 58. Abbott Company Information Table 59. Abbott Business Overview Table 60. Abbott Preventive Vaccines Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 61. Abbott Preventive Vaccines Product Portfolio Table 62. Abbott Recent Development Table 63. Sanofi Company Information Table 64. Sanofi Business Overview Table 65. Sanofi Preventive Vaccines Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 66. Sanofi Preventive Vaccines Product Portfolio Table 67. Sanofi Recent Development Table 68. GlaxoSmithKline Company Information Table 69. GlaxoSmithKline Business Overview Table 70. GlaxoSmithKline Preventive Vaccines Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 71. GlaxoSmithKline Preventive Vaccines Product Portfolio Table 72. GlaxoSmithKline Recent Development Table 73. AstraZeneca Company Information Table 74. AstraZeneca Business Overview Table 75. AstraZeneca Preventive Vaccines Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 76. AstraZeneca Preventive Vaccines Product Portfolio Table 77. AstraZeneca Recent Development Table 78. Serum Institute of India Company Information Table 79. Serum Institute of India Business Overview Table 80. Serum Institute of India Preventive Vaccines Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 81. Serum Institute of India Preventive Vaccines Product Portfolio Table 82. Serum Institute of India Recent Development Table 83. CSL Ltd Company Information Table 84. CSL Ltd Business Overview Table 85. CSL Ltd Preventive Vaccines Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 86. CSL Ltd Preventive Vaccines Product Portfolio Table 87. CSL Ltd Recent Development Table 88. North America Preventive Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 89. North America Preventive Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 90. North America Preventive Vaccines Sales by Type (2021-2026) & (doses) Table 91. North America Preventive Vaccines Sales by Type (2027-2032) & (doses) Table 92. North America Preventive Vaccines Sales Price by Type (2021-2026) & (US$/dose) Table 93. North America Preventive Vaccines Sales Price by Type (2027-2032) & (US$/dose) Table 94. North America Preventive Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 95. North America Preventive Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 96. North America Preventive Vaccines Sales by Application (2021-2026) & (doses) Table 97. North America Preventive Vaccines Sales by Application (2027-2032) & (doses) Table 98. North America Preventive Vaccines Sales Price by Application (2021-2026) & (US$/dose) Table 99. North America Preventive Vaccines Sales Price by Application (2027-2032) & (US$/dose) Table 100. North America Preventive Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. North America Preventive Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 102. North America Preventive Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 103. North America Preventive Vaccines Sales by Country (2021 VS 2025 VS 2032) & (doses) Table 104. North America Preventive Vaccines Sales by Country (2021-2026) & (doses) Table 105. North America Preventive Vaccines Sales by Country (2027-2032) & (doses) Table 106. North America Preventive Vaccines Sales Price by Country (2021-2026) & (US$/dose) Table 107. North America Preventive Vaccines Sales Price by Country (2027-2032) & (US$/dose) Table 108. United States Preventive Vaccines Revenue (2021-2032) & (US$ Million) Table 109. Canada Preventive Vaccines Revenue (2021-2032) & (US$ Million) Table 110. Mexico Preventive Vaccines Revenue (2021-2032) & (US$ Million) Table 111. Europe Preventive Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 112. Europe Preventive Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 113. Europe Preventive Vaccines Sales by Type (2021-2026) & (doses) Table 114. Europe Preventive Vaccines Sales by Type (2027-2032) & (doses) Table 115. Europe Preventive Vaccines Sales Price by Type (2021-2026) & (US$/dose) Table 116. Europe Preventive Vaccines Sales Price by Type (2027-2032) & (US$/dose) Table 117. Europe Preventive Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 118. Europe Preventive Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 119. Europe Preventive Vaccines Sales by Application (2021-2026) & (doses) Table 120. Europe Preventive Vaccines Sales by Application (2027-2032) & (doses) Table 121. Europe Preventive Vaccines Sales Price by Application (2021-2026) & (US$/dose) Table 122. Europe Preventive Vaccines Sales Price by Application (2027-2032) & (US$/dose) Table 123. Europe Preventive Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. Europe Preventive Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 125. Europe Preventive Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 126. Europe Preventive Vaccines Sales by Country (2021 VS 2025 VS 2032) & (doses) Table 127. Europe Preventive Vaccines Sales by Country (2021-2026) & (doses) Table 128. Europe Preventive Vaccines Sales by Country (2027-2032) & (doses) Table 129. Europe Preventive Vaccines Sales Price by Country (2021-2026) & (US$/dose) Table 130. Europe Preventive Vaccines Sales Price by Country (2027-2032) & (US$/dose) Table 131. Germany Preventive Vaccines Revenue (2021-2032) & (US$ Million) Table 132. France Preventive Vaccines Revenue (2021-2032) & (US$ Million) Table 133. U.K. Preventive Vaccines Revenue (2021-2032) & (US$ Million) Table 134. Italy Preventive Vaccines Revenue (2021-2032) & (US$ Million) Table 135. Russia Preventive Vaccines Revenue (2021-2032) & (US$ Million) Table 136. Spain Preventive Vaccines Revenue (2021-2032) & (US$ Million) Table 137. Netherlands Preventive Vaccines Revenue (2021-2032) & (US$ Million) Table 138. Switzerland Preventive Vaccines Revenue (2021-2032) & (US$ Million) Table 139. Sweden Preventive Vaccines Revenue (2021-2032) & (US$ Million) Table 140. Poland Preventive Vaccines Revenue (2021-2032) & (US$ Million) Table 141. China Preventive Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 142. China Preventive Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 143. China Preventive Vaccines Sales by Type (2021-2026) & (doses) Table 144. China Preventive Vaccines Sales by Type (2027-2032) & (doses) Table 145. China Preventive Vaccines Sales Price by Type (2021-2026) & (US$/dose) Table 146. China Preventive Vaccines Sales Price by Type (2027-2032) & (US$/dose) Table 147. China Preventive Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 148. China Preventive Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 149. China Preventive Vaccines Sales by Application (2021-2026) & (doses) Table 150. China Preventive Vaccines Sales by Application (2027-2032) & (doses) Table 151. China Preventive Vaccines Sales Price by Application (2021-2026) & (US$/dose) Table 152. China Preventive Vaccines Sales Price by Application (2027-2032) & (US$/dose) Table 153. Asia Preventive Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 154. Asia Preventive Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 155. Asia Preventive Vaccines Sales by Type (2021-2026) & (doses) Table 156. Asia Preventive Vaccines Sales by Type (2027-2032) & (doses) Table 157. Asia Preventive Vaccines Sales Price by Type (2021-2026) & (US$/dose) Table 158. Asia Preventive Vaccines Sales Price by Type (2027-2032) & (US$/dose) Table 159. Asia Preventive Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 160. Asia Preventive Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 161. Asia Preventive Vaccines Sales by Application (2021-2026) & (doses) Table 162. Asia Preventive Vaccines Sales by Application (2027-2032) & (doses) Table 163. Asia Preventive Vaccines Sales Price by Application (2021-2026) & (US$/dose) Table 164. Asia Preventive Vaccines Sales Price by Application (2027-2032) & (US$/dose) Table 165. Asia Preventive Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 166. Asia Preventive Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 167. Asia Preventive Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 168. Asia Preventive Vaccines Sales by Country (2021 VS 2025 VS 2032) & (doses) Table 169. Asia Preventive Vaccines Sales by Country (2021-2026) & (doses) Table 170. Asia Preventive Vaccines Sales by Country (2027-2032) & (doses) Table 171. Asia Preventive Vaccines Sales Price by Country (2021-2026) & (US$/dose) Table 172. Asia Preventive Vaccines Sales Price by Country (2027-2032) & (US$/dose) Table 173. Japan Preventive Vaccines Revenue (2021-2032) & (US$ Million) Table 174. South Korea Preventive Vaccines Revenue (2021-2032) & (US$ Million) Table 175. India Preventive Vaccines Revenue (2021-2032) & (US$ Million) Table 176. Australia Preventive Vaccines Revenue (2021-2032) & (US$ Million) Table 177. Taiwan Preventive Vaccines Revenue (2021-2032) & (US$ Million) Table 178. Southeast Asia Preventive Vaccines Revenue (2021-2032) & (US$ Million) Table 179. SAMEA Preventive Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 180. SAMEA Preventive Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 181. SAMEA Preventive Vaccines Sales by Type (2021-2026) & (doses) Table 182. SAMEA Preventive Vaccines Sales by Type (2027-2032) & (doses) Table 183. SAMEA Preventive Vaccines Sales Price by Type (2021-2026) & (US$/dose) Table 184. SAMEA Preventive Vaccines Sales Price by Type (2027-2032) & (US$/dose) Table 185. SAMEA Preventive Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 186. SAMEA Preventive Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 187. SAMEA Preventive Vaccines Sales by Application (2021-2026) & (doses) Table 188. SAMEA Preventive Vaccines Sales by Application (2027-2032) & (doses) Table 189. SAMEA Preventive Vaccines Sales Price by Application (2021-2026) & (US$/dose) Table 190. SAMEA Preventive Vaccines Sales Price by Application (2027-2032) & (US$/dose) Table 191. SAMEA Preventive Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 192. SAMEA Preventive Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 193. SAMEA Preventive Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 194. SAMEA Preventive Vaccines Sales by Country (2021 VS 2025 VS 2032) & (doses) Table 195. SAMEA Preventive Vaccines Sales by Country (2021-2026) & (doses) Table 196. SAMEA Preventive Vaccines Sales by Country (2027-2032) & (doses) Table 197. SAMEA Preventive Vaccines Sales Price by Country (2021-2026) & (US$/dose) Table 198. SAMEA Preventive Vaccines Sales Price by Country (2027-2032) & (US$/dose) Table 199. Brazil Preventive Vaccines Revenue (2021-2032) & (US$ Million) Table 200. Argentina Preventive Vaccines Revenue (2021-2032) & (US$ Million) Table 201. Chile Preventive Vaccines Revenue (2021-2032) & (US$ Million) Table 202. Colombia Preventive Vaccines Revenue (2021-2032) & (US$ Million) Table 203. Peru Preventive Vaccines Revenue (2021-2032) & (US$ Million) Table 204. Saudi Arabia Preventive Vaccines Revenue (2021-2032) & (US$ Million) Table 205. Israel Preventive Vaccines Revenue (2021-2032) & (US$ Million) Table 206. UAE Preventive Vaccines Revenue (2021-2032) & (US$ Million) Table 207. Turkey Preventive Vaccines Revenue (2021-2032) & (US$ Million) Table 208. Iran Preventive Vaccines Revenue (2021-2032) & (US$ Million) Table 209. Egypt Preventive Vaccines Revenue (2021-2032) & (US$ Million) Table 210. Key Raw Materials Table 211. Raw Materials Key Suppliers Table 212. Preventive Vaccines Distributors List Table 213. Preventive Vaccines Customers List Table 214. Research Programs/Design for This Report Table 215. Authors List of This Report Table 216. Secondary Sources Table 217. Primary Sources List of Figures Figure 1. Preventive Vaccines Image Figure 2. Global Preventive Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Preventive Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 4. Intradermal Shot Image Figure 5. Intramuscular Injection Image Figure 6. Nasal Spray Image Figure 7. Global Preventive Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Preventive Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Image Figure 10. Clinic Image Figure 11. Other Image Figure 12. Global Preventive Vaccines Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Preventive Vaccines Revenue (2021-2032) & (US$ Million) Figure 14. Global Preventive Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Preventive Vaccines Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Preventive Vaccines Revenue Market Share by Region (2021-2032) Figure 17. Global Preventive Vaccines Sales (2021-2032) & (doses) Figure 18. Global Preventive Vaccines Sales by Region: 2021 VS 2025 VS 2032 (doses) Figure 19. Global Preventive Vaccines Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Preventive Vaccines Sales YoY (2021-2032) & (doses) Figure 21. Europe Preventive Vaccines Sales YoY (2021-2032) & (doses) Figure 22. China Preventive Vaccines Sales YoY (2021-2032) & (doses) Figure 23. Asia (Excluding China) Preventive Vaccines Sales YoY (2021-2032) & (doses) Figure 24. South America, Middle East and Africa Preventive Vaccines Sales YoY (2021-2032) & (doses) Figure 25. Global Preventive Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Preventive Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Preventive Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Preventive Vaccines Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Preventive Vaccines Revenue Market Share by Type (2021-2032) Figure 31. Global Preventive Vaccines Sales by Type (2021 VS 2025 VS 2032) & (doses) Figure 32. Global Preventive Vaccines Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Preventive Vaccines Sales Market Share by Type (2021-2032) Figure 34. Global Preventive Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Preventive Vaccines Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Preventive Vaccines Revenue Market Share by Application (2021-2032) Figure 37. Global Preventive Vaccines Sales by Application (2021 VS 2025 VS 2032) & (doses) Figure 38. Global Preventive Vaccines Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Preventive Vaccines Sales Market Share by Application (2021-2032) Figure 40. North America Preventive Vaccines Revenue Share by Type (2021-2032) Figure 41. North America Preventive Vaccines Sales Share by Type (2021-2032) Figure 42. North America Preventive Vaccines Revenue Share by Application (2021-2032) Figure 43. North America Preventive Vaccines Sales Share by Application (2021-2032) Figure 44. North America Preventive Vaccines Revenue Share by Country (2021-2032) Figure 45. North America Preventive Vaccines Sales Share by Country (2021-2032) Figure 46. Europe Preventive Vaccines Revenue Share by Type (2021-2032) Figure 47. Europe Preventive Vaccines Sales Share by Type (2021-2032) Figure 48. Europe Preventive Vaccines Revenue Share by Application (2021-2032) Figure 49. Europe Preventive Vaccines Sales Share by Application (2021-2032) Figure 50. Europe Preventive Vaccines Revenue Share by Country (2021-2032) Figure 51. Europe Preventive Vaccines Sales Share by Country (2021-2032) Figure 52. China Preventive Vaccines Revenue Share by Type (2021-2032) Figure 53. China Preventive Vaccines Sales Share by Type (2021-2032) Figure 54. China Preventive Vaccines Revenue Share by Application (2021-2032) Figure 55. China Preventive Vaccines Sales Share by Application (2021-2032) Figure 56. Asia Preventive Vaccines Revenue Share by Type (2021-2032) Figure 57. Asia Preventive Vaccines Sales Share by Type (2021-2032) Figure 58. Asia Preventive Vaccines Revenue Share by Application (2021-2032) Figure 59. Asia Preventive Vaccines Sales Share by Application (2021-2032) Figure 60. Asia Preventive Vaccines Revenue Share by Country (2021-2032) Figure 61. Asia Preventive Vaccines Sales Share by Country (2021-2032) Figure 62. SAMEA Preventive Vaccines Revenue Share by Type (2021-2032) Figure 63. SAMEA Preventive Vaccines Sales Share by Type (2021-2032) Figure 64. SAMEA Preventive Vaccines Revenue Share by Application (2021-2032) Figure 65. SAMEA Preventive Vaccines Sales Share by Application (2021-2032) Figure 66. SAMEA Preventive Vaccines Revenue Share by Country (2021-2032) Figure 67. SAMEA Preventive Vaccines Sales Share by Country (2021-2032) Figure 68. Preventive Vaccines Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Preventive Vaccines Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Intradermal Shot
  • Intramuscular Injection
  • Nasal Spray
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Abbott
  • Sanofi
  • GlaxoSmithKline
  • AstraZeneca
  • Serum Institute of India
  • CSL Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Preventive Vaccines Market by Type
  3. 1.2.1 Global Preventive Vaccines Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Intradermal Shot
  5. 1.2.3 Intramuscular Injection
  6. 1.2.4 Nasal Spray
  7. 1.3 Preventive Vaccines Market by Application
  8. 1.3.1 Global Preventive Vaccines Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Clinic
  11. 1.3.4 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Preventive Vaccines Market Dynamics
  1. 2.1 Preventive Vaccines Industry Trends
  2. 2.2 Preventive Vaccines Industry Drivers
  3. 2.3 Preventive Vaccines Industry Opportunities and Challenges
  4. 2.4 Preventive Vaccines Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Preventive Vaccines Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Preventive Vaccines Revenue by Region
  3. 3.2.1 Global Preventive Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Preventive Vaccines Revenue by Region (2021-2026)
  5. 3.2.3 Global Preventive Vaccines Revenue by Region (2027-2032)
  6. 3.2.4 Global Preventive Vaccines Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Preventive Vaccines Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Preventive Vaccines Sales by Region
  9. 3.4.1 Global Preventive Vaccines Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Preventive Vaccines Sales by Region (2021-2026)
  11. 3.4.3 Global Preventive Vaccines Sales by Region (2027-2032)
  12. 3.4.4 Global Preventive Vaccines Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Preventive Vaccines Revenue by Manufacturers
  2. 4.1.1 Global Preventive Vaccines Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Preventive Vaccines Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Preventive Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Preventive Vaccines Sales by Manufacturers
  6. 4.2.1 Global Preventive Vaccines Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Preventive Vaccines Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Preventive Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Preventive Vaccines Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Preventive Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Preventive Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Preventive Vaccines Manufacturers, Product Type & Application
  13. 4.7 Global Preventive Vaccines Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Preventive Vaccines Market CR5 and HHI
  16. 4.8.2 2025 Preventive Vaccines Tier 1, Tier 2, and Tier 3
5 Preventive Vaccines Market by Type
  1. 5.1 Global Preventive Vaccines Revenue by Type
  2. 5.1.1 Global Preventive Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Preventive Vaccines Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Preventive Vaccines Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Preventive Vaccines Sales by Type
  6. 5.2.1 Global Preventive Vaccines Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Preventive Vaccines Sales by Type (2021-2032) & (doses)
  8. 5.2.3 Global Preventive Vaccines Sales Market Share by Type (2021-2032)
  9. 5.3 Global Preventive Vaccines Price by Type
6 Preventive Vaccines Market by Application
  1. 6.1 Global Preventive Vaccines Revenue by Application
  2. 6.1.1 Global Preventive Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Preventive Vaccines Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Preventive Vaccines Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Preventive Vaccines Sales by Application
  6. 6.2.1 Global Preventive Vaccines Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Preventive Vaccines Sales by Application (2021-2032) & (doses)
  8. 6.2.3 Global Preventive Vaccines Sales Market Share by Application (2021-2032)
  9. 6.3 Global Preventive Vaccines Price by Application
7 Company Profiles
  1. 7.1 Abbott
  2. 7.1.1 Abbott Company Information
  3. 7.1.2 Abbott Business Overview
  4. 7.1.3 Abbott Preventive Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Abbott Preventive Vaccines Product Portfolio
  6. 7.1.5 Abbott Recent Developments
  7. 7.2 Sanofi
  8. 7.2.1 Sanofi Company Information
  9. 7.2.2 Sanofi Business Overview
  10. 7.2.3 Sanofi Preventive Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sanofi Preventive Vaccines Product Portfolio
  12. 7.2.5 Sanofi Recent Developments
  13. 7.3 GlaxoSmithKline
  14. 7.3.1 GlaxoSmithKline Company Information
  15. 7.3.2 GlaxoSmithKline Business Overview
  16. 7.3.3 GlaxoSmithKline Preventive Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 GlaxoSmithKline Preventive Vaccines Product Portfolio
  18. 7.3.5 GlaxoSmithKline Recent Developments
  19. 7.4 AstraZeneca
  20. 7.4.1 AstraZeneca Company Information
  21. 7.4.2 AstraZeneca Business Overview
  22. 7.4.3 AstraZeneca Preventive Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 AstraZeneca Preventive Vaccines Product Portfolio
  24. 7.4.5 AstraZeneca Recent Developments
  25. 7.5 Serum Institute of India
  26. 7.5.1 Serum Institute of India Company Information
  27. 7.5.2 Serum Institute of India Business Overview
  28. 7.5.3 Serum Institute of India Preventive Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Serum Institute of India Preventive Vaccines Product Portfolio
  30. 7.5.5 Serum Institute of India Recent Developments
  31. 7.6 CSL Ltd
  32. 7.6.1 CSL Ltd Company Information
  33. 7.6.2 CSL Ltd Business Overview
  34. 7.6.3 CSL Ltd Preventive Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 CSL Ltd Preventive Vaccines Product Portfolio
  36. 7.6.5 CSL Ltd Recent Developments
8 North America
  1. 8.1 North America Preventive Vaccines Market Size by Type
  2. 8.1.1 North America Preventive Vaccines Revenue by Type (2021-2032)
  3. 8.1.2 North America Preventive Vaccines Sales by Type (2021-2032)
  4. 8.1.3 North America Preventive Vaccines Price by Type (2021-2032)
  5. 8.2 North America Preventive Vaccines Market Size by Application
  6. 8.2.1 North America Preventive Vaccines Revenue by Application (2021-2032)
  7. 8.2.2 North America Preventive Vaccines Sales by Application (2021-2032)
  8. 8.2.3 North America Preventive Vaccines Price by Application (2021-2032)
  9. 8.3 North America Preventive Vaccines Market Size by Country
  10. 8.3.1 North America Preventive Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Preventive Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Preventive Vaccines Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Preventive Vaccines Market Size by Type
  2. 9.1.1 Europe Preventive Vaccines Revenue by Type (2021-2032)
  3. 9.1.2 Europe Preventive Vaccines Sales by Type (2021-2032)
  4. 9.1.3 Europe Preventive Vaccines Price by Type (2021-2032)
  5. 9.2 Europe Preventive Vaccines Market Size by Application
  6. 9.2.1 Europe Preventive Vaccines Revenue by Application (2021-2032)
  7. 9.2.2 Europe Preventive Vaccines Sales by Application (2021-2032)
  8. 9.2.3 Europe Preventive Vaccines Price by Application (2021-2032)
  9. 9.3 Europe Preventive Vaccines Market Size by Country
  10. 9.3.1 Europe Preventive Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Preventive Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Preventive Vaccines Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Preventive Vaccines Market Size by Type
  2. 10.1.1 China Preventive Vaccines Revenue by Type (2021-2032)
  3. 10.1.2 China Preventive Vaccines Sales by Type (2021-2032)
  4. 10.1.3 China Preventive Vaccines Price by Type (2021-2032)
  5. 10.2 China Preventive Vaccines Market Size by Application
  6. 10.2.1 China Preventive Vaccines Revenue by Application (2021-2032)
  7. 10.2.2 China Preventive Vaccines Sales by Application (2021-2032)
  8. 10.2.3 China Preventive Vaccines Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Preventive Vaccines Market Size by Type
  2. 11.1.1 Asia Preventive Vaccines Revenue by Type (2021-2032)
  3. 11.1.2 Asia Preventive Vaccines Sales by Type (2021-2032)
  4. 11.1.3 Asia Preventive Vaccines Price by Type (2021-2032)
  5. 11.2 Asia Preventive Vaccines Market Size by Application
  6. 11.2.1 Asia Preventive Vaccines Revenue by Application (2021-2032)
  7. 11.2.2 Asia Preventive Vaccines Sales by Application (2021-2032)
  8. 11.2.3 Asia Preventive Vaccines Price by Application (2021-2032)
  9. 11.3 Asia Preventive Vaccines Market Size by Country
  10. 11.3.1 Asia Preventive Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Preventive Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Preventive Vaccines Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Preventive Vaccines Market Size by Type
  2. 12.1.1 SAMEA Preventive Vaccines Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Preventive Vaccines Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Preventive Vaccines Price by Type (2021-2032)
  5. 12.2 SAMEA Preventive Vaccines Market Size by Application
  6. 12.2.1 SAMEA Preventive Vaccines Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Preventive Vaccines Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Preventive Vaccines Price by Application (2021-2032)
  9. 12.3 SAMEA Preventive Vaccines Market Size by Country
  10. 12.3.1 SAMEA Preventive Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Preventive Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Preventive Vaccines Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Preventive Vaccines Value Chain Analysis
  2. 13.1.1 Preventive Vaccines Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Preventive Vaccines Production Mode & Process
  6. 13.2 Preventive Vaccines Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Preventive Vaccines Distributors
  9. 13.2.3 Preventive Vaccines Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst